Figure 1From: Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer Treatment plan for a patient treated with SBRT to a dose of 36 Gy / 3 fractions following neoadjuvant chemotherapy with gemcitabine/capecitabine. Back to article page